Mark Olde Riekerink,
Senior Business Development Manager,
Micronit Microtechnologies BV
As Micronit’s Sr Business Development Manager in the field of Life Science Research, Mark Olde Riekerink focuses on the development of lab-on-a-chip devices in application areas like genomics and single-cell analysis. In 2007, he started working for Micronit as an R&D Project Manager. As of 2001, Mark had been working at Philips Corporate R&D (Applied Technologies, Eindhoven) in several semiconductor and healthcare related projects. Mark received his Ph.D. degree in Polymer Chemistry and Biomaterials Research at the University of Twente (Enschede, The Netherlands) in 2001.
Microfluidics Applications in the Life Sciences Sector
Tuesday, 21 June 2022 at 14:30
Add to Calendar ▼2022-06-21 14:30:002022-06-21 15:30:00Europe/LondonMicrofluidics Applications in the Life Sciences SectorLab-on-a-Chip and Microfluidics Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Microfluidics is the science of manipulating small volumes of liquids. This field is rapidly evolving and can have an enormous impact on the progress in science and healthcare. This usually is executed on microchips made with manufacturing techniques also used in the semiconductor industry, like lithography, etching and thin film deposition. The chips contain small channels, which enable accurate control of liquids and chemical reactions. The use of small volumes allows quicker temperature shifts and faster liquid displacement. Moreover, microfluidics enables the automation and integration of complex operations on-chip, with reduced sample and expensive reagent volumes. With such properties, microfluidics can fit applications in the healthcare sector along with other microtechnologies. The approach starts from a conceptual design to prototyping to a final design and process transfer for volume manufacturing. A flexible approach allows the choice of a variety of materials and hybrid material combinations and customized designs e.g. for successful integration of multiple functions. This approach is of particular interest for developing relative complex designs with multiple micro- and nanostructures and functionalities on board. The collaboration of life sciences and microfluidics companies can help in developing technologies that can also reduce development costs, speed up time-to-market and increase success rates for cost-effective commercialization. During this talk, examples of industrial solutions and recent technology developments will be presented, with special focus on the life sciences sector.
Add to Calendar ▼2022-06-21 00:00:002022-06-22 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics Europe 2022Lab-on-a-Chip and Microfluidics Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com